Charles Schwab Investment Management Inc Beam Therapeutics Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 629,492 shares of BEAM stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
629,492
Previous 593,266 6.11%
Holding current value
$17.8 Million
Previous $13.9 Million 10.95%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$22.57 - $33.14 $817,620 - $1.2 Million
36,226 Added 6.11%
629,492 $15.4 Million
Q2 2024

Aug 12, 2024
BUY
$21.22 - $32.66 $296,952 - $457,044
13,994 Added 2.42%
593,266 $13.9 Million
Q1 2024

May 08, 2024
BUY
$23.46 - $45.07 $188,524 - $362,182
8,036 Added 1.41%
579,272 $19.1 Million
Q4 2023

Feb 06, 2024
BUY
$17.69 - $30.76 $527,621 - $917,447
29,826 Added 5.51%
571,236 $15.5 Million
Q3 2023

Nov 08, 2023
BUY
$23.01 - $32.46 $920,169 - $1.3 Million
39,990 Added 7.98%
541,410 $13 Million
Q2 2023

Aug 09, 2023
BUY
$29.32 - $35.99 $1.11 Million - $1.36 Million
37,806 Added 8.15%
501,420 $16 Million
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $74,169 - $120,023
2,460 Added 0.53%
463,614 $14.2 Million
Q4 2022

Feb 13, 2023
BUY
$36.73 - $51.6 $339,642 - $477,145
9,247 Added 2.05%
461,154 $18 Million
Q3 2022

Nov 14, 2022
BUY
$39.79 - $70.31 $2.17 Million - $3.83 Million
54,458 Added 13.7%
451,907 $21.5 Million
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $792,275 - $1.65 Million
26,533 Added 7.15%
397,449 $15.4 Million
Q1 2022

May 13, 2022
BUY
$53.73 - $82.16 $1.24 Million - $1.9 Million
23,092 Added 6.64%
370,916 $21.3 Million
Q4 2021

Feb 11, 2022
BUY
$68.02 - $99.06 $972,958 - $1.42 Million
14,304 Added 4.29%
347,824 $27.7 Million
Q3 2021

Nov 16, 2021
BUY
$84.37 - $133.6 $6.92 Million - $11 Million
82,078 Added 32.64%
333,520 $29 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $2.04 Million - $4.09 Million
31,750 Added 14.45%
251,442 $32.4 Million
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $1.14 Million - $1.93 Million
16,010 Added 7.86%
219,692 $17.6 Million
Q4 2020

Feb 16, 2021
BUY
$22.24 - $95.63 $715,483 - $3.08 Million
32,171 Added 18.76%
203,682 $16.6 Million
Q3 2020

Nov 13, 2020
BUY
$19.0 - $30.57 $1.69 Million - $2.72 Million
88,909 Added 107.64%
171,511 $4.22 Million
Q2 2020

Aug 14, 2020
BUY
$15.26 - $28.66 $863,670 - $1.62 Million
56,597 Added 217.64%
82,602 $2.31 Million
Q1 2020

May 15, 2020
BUY
$13.31 - $29.2 $346,126 - $759,346
26,005 New
26,005 $469,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.99B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email